All News #Library
Biotech
OverT Bio Forms Advisory Board for OVT-101 in Ovarian Cancer
23 Mar 2026 //
PHARMIWEB
OverT Bio Receives $120K G-Rex® Grant To Propel Tumor Cell Therapy
22 Nov 2024 //
BUSINESSWIRE
OverT Bio raises $16 million for innovative immune cell therapies.
06 May 2024 //
BUSINESSWIRE

Market Place
Sourcing Support